Review decision- December 2007
Review of NICE Technology Appraisal Guidance No 82; on the use of tacrolimus and pimecrolimus for the treatment of atopic eczema
Following consultation, the majority of comments received have led to the decision to defer the review of the original guidance until January 2009. During that time, the evidence base will be re-assessed to ascertain whether there is a need to review the guidance.
21 December 2007
This page was last updated: 30 March 2010